Literature DB >> 16759651

Progesterone receptor antagonist is effective in relieving neuropathic pain.

Daisuke Kondo1, Ritsuko Yabe, Takashi Kurihara, Hironao Saegusa, Shuqin Zong, Tsutomu Tanabe.   

Abstract

Injury to the spinal nerves of mice induces allodynia and hyperalgesia. Intrathecal injection of the progesterone/estrogen receptor antagonist ICI 182,780 produced antinociceptive effects. Co-administration of estrogen did not reduce but tended to enhance the antinociceptive effect of ICI 182,780. On the other hand, co-administration of progesterone dose-dependently reduced the antinociceptive effect of ICI 182,780, indicating that the antinociceptive effect is through antiprogesterone receptor activity of ICI 182,780. These results suggest that spinal progesterone receptors play an important role in neuropathic pain, and that controlling the activity of progesterone receptors may be of great importance in the treatment of neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16759651     DOI: 10.1016/j.ejphar.2006.05.010

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Involvement of estrogen in rapid pain modulation in the rat spinal cord.

Authors:  Yan Zhang; Ning Lü; Zhi-Qi Zhao; Yu-Qiu Zhang
Journal:  Neurochem Res       Date:  2012-08-19       Impact factor: 3.996

2.  Upregulation of casein kinase 1epsilon in dorsal root ganglia and spinal cord after mouse spinal nerve injury contributes to neuropathic pain.

Authors:  Eri Sakurai; Takashi Kurihara; Kasumi Kouchi; Hironao Saegusa; Shuqin Zong; Tsutomu Tanabe
Journal:  Mol Pain       Date:  2009-12-18       Impact factor: 3.395

3.  17beta-estradiol activates estrogen receptor beta-signalling and inhibits transient receptor potential vanilloid receptor 1 activation by capsaicin in adult rat nociceptor neurons.

Authors:  Shenghong Xu; Ying Cheng; Janet R Keast; Peregrine B Osborne
Journal:  Endocrinology       Date:  2008-07-10       Impact factor: 4.736

4.  Progesterone prevents development of neuropathic pain in a rat model: Timing and duration of treatment are critical.

Authors:  Liliane J Dableh; James L Henry
Journal:  J Pain Res       Date:  2011-04-05       Impact factor: 3.133

5.  Progesterone produces antinociceptive and neuroprotective effects in rats with microinjected lysophosphatidic acid in the trigeminal nerve root.

Authors:  Min Ji Kim; Hea Jung Shin; Kyoung Ae Won; Kui Ye Yang; Jin Sook Ju; Yoon Yub Park; Jae Sik Park; Yong Cheol Bae; Dong Kuk Ahn
Journal:  Mol Pain       Date:  2012-03-19       Impact factor: 3.395

6.  Comprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in Trigeminal ganglia.

Authors:  Stavros Manteniotis; Ramona Lehmann; Caroline Flegel; Felix Vogel; Adrian Hofreuter; Benjamin S P Schreiner; Janine Altmüller; Christian Becker; Nicole Schöbel; Hanns Hatt; Günter Gisselmann
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

7.  Systems pharmacology exploration of botanic drug pairs reveals the mechanism for treating different diseases.

Authors:  Wei Zhou; Jinan Wang; Ziyin Wu; Chao Huang; Aiping Lu; Yonghua Wang
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

8.  The effect of progesteron for expression delta (δ) opioid receptor spinal cord through peripheral nerve injury.

Authors:  Bambang Priyanto; Rohadi Muhammad Rosyidi; Andi Asadul Islam; Agus Turchan; Yusra Pintaningrum
Journal:  Ann Med Surg (Lond)       Date:  2022-02-11

Review 9.  Progesterone: A Steroid with Wide Range of Effects in Physiology as Well as Human Medicine.

Authors:  Lucie Kolatorova; Jana Vitku; Josef Suchopar; Martin Hill; Antonin Parizek
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.